AU1994492A - Acyclic 6-phenylselenenyl pyrimidine nucleosides - Google Patents

Acyclic 6-phenylselenenyl pyrimidine nucleosides

Info

Publication number
AU1994492A
AU1994492A AU19944/92A AU1994492A AU1994492A AU 1994492 A AU1994492 A AU 1994492A AU 19944/92 A AU19944/92 A AU 19944/92A AU 1994492 A AU1994492 A AU 1994492A AU 1994492 A AU1994492 A AU 1994492A
Authority
AU
Australia
Prior art keywords
phenylselenenyl
acyclic
pyrimidine nucleosides
nucleosides
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19944/92A
Inventor
Raymond F. Schinazi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Branded Pharmaceutical Products R&D Inc
Original Assignee
Baker Cummins Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Cummins Pharmaceuticals Inc filed Critical Baker Cummins Pharmaceuticals Inc
Publication of AU1994492A publication Critical patent/AU1994492A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
AU19944/92A 1991-07-22 1992-05-08 Acyclic 6-phenylselenenyl pyrimidine nucleosides Abandoned AU1994492A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73334691A 1991-07-22 1991-07-22
US733346 1991-07-22

Publications (1)

Publication Number Publication Date
AU1994492A true AU1994492A (en) 1993-02-23

Family

ID=24947232

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19944/92A Abandoned AU1994492A (en) 1991-07-22 1992-05-08 Acyclic 6-phenylselenenyl pyrimidine nucleosides

Country Status (2)

Country Link
AU (1) AU1994492A (en)
WO (1) WO1993002044A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
CN1092647C (en) * 1996-02-22 2002-10-16 三进制药株式会社 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for preparation thereof and compositions containing the same as active ingredients
GB0400290D0 (en) 2004-01-08 2004-02-11 Medivir Ab dUTPase inhibitors
WO2009005693A1 (en) 2007-06-29 2009-01-08 Gilead Sciences, Inc. Novel hiv reverse transcriptase inhibitors
EA200971115A1 (en) 2007-06-29 2010-04-30 Корея Рисерч Инститьют Оф Кемикал Текнолоджи NEW HIV REVERSE TRANSCRIPTASE INHIBITORS
KR20100092960A (en) 2007-12-21 2010-08-23 한국화학연구원 Processes for preparing hiv reverse transcriptase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH676712A5 (en) * 1988-03-31 1991-02-28 Mitsubishi Chem Ind

Also Published As

Publication number Publication date
WO1993002044A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
EP0407342A3 (en) Pyrimidine derivatives
AU638496B2 (en) Acyl-biphenylyl-alkyl pyrimidine derivatives
ZA927569B (en) Substituted pyrimidines
AU3388893A (en) Pyrimidine derivatives
GB9218810D0 (en) Antiviral pyrimidine nucleosides
AU6550394A (en) Novel pyrimidine nucleosides
AU8033891A (en) Pyrimidine derivatives
OA09718A (en) Nematocide pyrimidine derivatives.
AU638840B2 (en) Pyrimidine derivative
AU1994492A (en) Acyclic 6-phenylselenenyl pyrimidine nucleosides
AU7826591A (en) Anti-hbv pyrimidine nucleoside
OA09715A (en) Nematocide pyrimidine derivatives.
AU655051B2 (en) Condensed pyrimidine derivative
OA09717A (en) Nematicidal pyrimidine derivatives.
ZA948297B (en) Pyrimidine derivatives
EP0457505A3 (en) Pyrimidine derivatives
GB9514268D0 (en) Pyrimidine nucleoside
AU6786896A (en) Pyrimidine nucleosides
EP0518190A3 (en) Alkenyloxyphenyl pyrimidines
GB2268741B (en) Pyrimidine compounds
GB9606264D0 (en) Pyrimidine nucleoside derivatives
AU7646791A (en) Pyrimidine derivatives
AU2952092A (en) Anti-hbv pyrimidine nucleoside
GB9113209D0 (en) Pyrimidine derivatives
GB9514267D0 (en) Pyrimidine nucleosides